PMC:7696151 / 78951-79142 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"2382","span":{"begin":86,"end":91},"obj":"Gene"},{"id":"2392","span":{"begin":186,"end":190},"obj":"Species"},{"id":"2407","span":{"begin":128,"end":131},"obj":"Chemical"},{"id":"2436","span":{"begin":164,"end":177},"obj":"Disease"}],"attributes":[{"id":"A2382","pred":"tao:has_database_id","subj":"2382","obj":"Gene:12043"},{"id":"A2392","pred":"tao:has_database_id","subj":"2392","obj":"Tax:10090"},{"id":"A2407","pred":"tao:has_database_id","subj":"2407","obj":"MESH:D006886"},{"id":"A2436","pred":"tao:has_database_id","subj":"2436","obj":"MESH:D009447"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"In the same way, Fenollar, et al. [153] demonstrated the efficacy of Obatoclax, a pan-Bcl-2 inhibitor, used in association with HCQ (3–60 mg/kg) or conventional in neuroblastoma-bearing mice."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T176","span":{"begin":164,"end":177},"obj":"Phenotype"}],"attributes":[{"id":"A176","pred":"hp_id","subj":"T176","obj":"http://purl.obolibrary.org/obo/HP_0003006"}],"text":"In the same way, Fenollar, et al. [153] demonstrated the efficacy of Obatoclax, a pan-Bcl-2 inhibitor, used in association with HCQ (3–60 mg/kg) or conventional in neuroblastoma-bearing mice."}

{"project":"LitCovid-sentences","denotations":[{"id":"T506","span":{"begin":0,"end":191},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In the same way, Fenollar, et al. [153] demonstrated the efficacy of Obatoclax, a pan-Bcl-2 inhibitor, used in association with HCQ (3–60 mg/kg) or conventional in neuroblastoma-bearing mice."}